About Tevapharm India Private Limited
Data last updated:
Tevapharm India Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ratiopharm Gmbh. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 December 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33111MH2000FTC326700. Its GSTIN is 27AABCR7561F1ZA (Maharashtra). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹700 Cr and a paid-up capital of ₹220.19 Cr. It was formerly known as Ratiopharm India Private Limited. It is led by directors including Nishank Bhargava and Pooja Singh.
Its last annual general meeting (AGM) was held on 01 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹459.24 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹66.56 Cr (net margin 14.5%) and EBITDA of ₹103.72 Cr (EBITDA margin 22.6%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 6% over five years.
The company has about 973 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tevapharm.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address8th Floor Tower C Times Square Andheri Kurla Road Gamdevi Marol Andh, Eri East, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Tevapharm India Private Limited
Tevapharm India has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U33111MH2000FTC326700, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33111MH2000FTC326700 | Current |
| U33111DL2000FTC268478 | Previous |
| U33111MH2000FTC129835 | Previous |
Business Activity of Tevapharm India Private Limited
The main business activity of Tevapharm India is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Tevapharm India Private Limited
Tevapharm India Private Limited is audited by SRBC & CO LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SRBC & CO LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Tevapharm India Private Limited
Tevapharm India has 4 current directors and 30 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nishank Bhargava | Director | 24 Feb 2022 | 4 Years 7 Months | Current |
| Pooja Singh Also directs: Teva Global Business Services Private Limited | Director | 03 Jun 2025 | 1 Years 4 Months | Current |
| Vinod Narayan Shetty | Director | 24 Aug 2021 | 5 Years 1 Months | Current |
| Gubbi Channappa Roopa | Director | 27 Jun 2024 | 2 Years 3 Months | Current |
Financials of Tevapharm India Private Limited FY 2025 filings available
Tevapharm India Private Limited reported revenue of ₹459.24 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Tevapharm India Private Limited
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Tevapharm India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹103.72 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹66.56 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Tevapharm India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 14.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tevapharm India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Tevapharm India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Tevapharm India Private Limited
Tevapharm India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Tevapharm India Private Limited
Tevapharm India Private Limited has a workforce of 973 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Tevapharm India Private Limited
Tevapharm India has 5 GST registrations: 4 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCR7561F1ZA | Maharashtra | Active | 01 Jul 2017 |
| 27AABCR7561F2Z9 | Maharashtra | Active | 11 Mar 2025 |
| 30AABCR7561F1ZN | Goa | Active | 01 Jul 2017 |
| 29AABCR7561F1Z6 | Karnataka | Active | 25 Nov 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Tevapharm India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Tevapharm India Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Tevapharm India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Tevapharm India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Tevapharm India Private Limited
Recent News on Tevapharm India Private Limited
Frequently Asked Questions about Tevapharm India Private Limited
Tevapharm India is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 December 2000 (26+ years old) and is registered under CIN U33111MH2000FTC326700.
Tevapharm India reported revenue of ₹459.24 Cr for FY 2025 (down 9% YoY).
Tevapharm India has 4 current directors:
- Nishank Bhargava - Director
- Pooja Singh - Director
- Vinod Narayan Shetty - Director
- Gubbi Channappa Roopa - Director
Tevapharm India reported a net profit of ₹66.56 Cr (net margin 14.5%) and EBITDA of ₹103.72 Cr (EBITDA margin 22.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Tevapharm India is 24% over three years and 6% over five years. In the latest year (FY 2025) revenue fell 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Tevapharm India is 27AABCR7561F1ZA, registered in Maharashtra. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 27AABCR7561F2Z9 (Maharashtra), 30AABCR7561F1ZN (Goa), 29AABCR7561F1Z6 (Karnataka).
The CIN (Corporate Identification Number) of Tevapharm India is U33111MH2000FTC326700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tevapharm India was incorporated on 01 December 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
Tevapharm India can be reached through the website tevapharm.com. Its registered office is in Mumbai, Maharashtra, India.